Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Feuerstein

Showing results (381-390 of 385) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 385 results.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Neuro-Oncology|February 13, 2010
A multigene predictor of outcome in glioblastomaHoward Colman, Li Zhang, Erik P Sulman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2006
Angiogenesis-independent tumor growth mediated by stem-like cancer cellsPer Ø Sakariassen, Lars Prestegarden, Jian Wang, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditisIgor Puzanov, Poornima Subramanian, Yan V Yatsynovich, et al.
Journal of Medicinal Chemistry|December 6, 1996
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonistsJ M Samanen, F E Ali, L S Barton, et al.
Pageof 39

Showing results (381-390 of 385) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 385 results.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Neuro-Oncology|February 13, 2010
A multigene predictor of outcome in glioblastomaHoward Colman, Li Zhang, Erik P Sulman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2006
Angiogenesis-independent tumor growth mediated by stem-like cancer cellsPer Ø Sakariassen, Lars Prestegarden, Jian Wang, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditisIgor Puzanov, Poornima Subramanian, Yan V Yatsynovich, et al.
Journal of Medicinal Chemistry|December 6, 1996
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonistsJ M Samanen, F E Ali, L S Barton, et al.
Pageof 39